Centessa Pharmaceuticals
Latest round
- Series A
Last raised
- Feb 2021
Total raised
- $250M
Investors
- 14
About Centessa Pharmaceuticals
Founded in 2021, based in Massachusetts, US, Centessa Pharmaceuticals Plc operates as a biopharmaceutical company that develops medicines and clinical programs to treat various diseases.5 billion upon achieving milestones. In June 2026, Farallon Capital Management acquired a 4,561,093 shares in Centessa Pharmaceuticals Plc.1% of minority stake and 9,370,093 shares in the company. Current CEO is Saurabh Saha. Centessa Subsidiaries are comprised of ApcinteX, Capella BioScience, Janpix, LockBody, Morphogen-IX, Orexia Therapeutics, Palladio Biosciences, PearlRiver Bio, Pega-One, and Z Factor. The current company's portfolio consists of four clinical-stage programs, including two that are in late-stage clinical development, and more than 10 additional programs spanning diseases with unmet needs across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the management team. The company plans to invest resources in accordance with a follow-the-data strategy, that will have consolidated capabilities to allow the advancement of each Centessa Subsidiary's respective programs.The June 2026, acquisition will enable the company to accelerate its growth. The March 2026 acquisition enables Eli Lilly and Company Limited to accelerate the advancement of Centessa Pharmaceuticals plc’s orexin receptor 2 agonist portfolio across a broad range of sleep-wake and neuroscience indications by combining Centessa’s capabilities with its global research, clinical, regulatory, and commercial resources.
Who invested in Centessa Pharmaceuticals
14 investors across 1 round
See all investors in Centessa Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 16, 2021
Amount
$250M
Investors
Questions about Centessa Pharmaceuticals
Who invested in Centessa Pharmaceuticals?
Centessa Pharmaceuticals has 14 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Centessa Pharmaceuticals raised?
Centessa Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Centessa Pharmaceuticals last raise money?
Centessa Pharmaceuticals's most recent round on record is a Series A, in Feb 2021.
What does Centessa Pharmaceuticals do?
Founded in 2021, based in Massachusetts, US, Centessa Pharmaceuticals Plc operates as a biopharmaceutical company that develops medicines and clinical programs to treat various diseases.
Where is Centessa Pharmaceuticals headquartered?
Centessa Pharmaceuticals is headquartered in Boston, US.
Which VCs invest in companies like Centessa Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Centessa Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Centessa Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.